Charles N. York II serves as Executive at Aeglea BioTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Charles N. York II has executed 63 insider transactions totaling $3.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 17, 2025 involved selling 4,062 shares valued at $36.2K.
Charles N. York II currently holds 294,715 shares of Aeglea BioTherapeutics, Inc. (AGLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles N. York II has been a net seller of AGLE stock. They have purchased $116.3K and sold $3.1M worth of shares.
Charles N. York II's most recent insider trade was on Nov 17, 2025, when they sold 4,062 shares at $8.91 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 15, 2025 | DAWN | $0 | Option Exercise | 2,250 | $N/A | Discretionary |
| Nov 15, 2025 | DAWN | $0 | Option Exercise | 1,375 | $N/A | Discretionary |
| Nov 15, 2025 | DAWN | $0 | Option Exercise | 6,625 | $N/A | Discretionary |
| Aug 18, 2025 | DAWN | $27.8K | Sale | 4,106 | $6.77 | Discretionary |
| Aug 15, 2025 | DAWN | $0 | Option Exercise | 6,625 | $N/A | Discretionary |
| Aug 15, 2025 | DAWN | $0 | Option Exercise | 6,625 | $N/A | Discretionary |
| Aug 15, 2025 | DAWN | $0 | Option Exercise | 2,250 | $N/A | Discretionary |
| Aug 15, 2025 | DAWN | $0 | Option Exercise | 1,375 | $N/A | Discretionary |
| Aug 16, 2024 | DAWN | $36.9K | Sale | 2,633 | $14.00 | Discretionary |
| Aug 15, 2024 | DAWN | $0 | Option Exercise | 1,375 | $N/A | Discretionary |
| Aug 15, 2024 | DAWN | $0 | Option Exercise | 2,250 | $N/A | Discretionary |
| Aug 15, 2024 | DAWN | $0 | Option Exercise | 6,625 | $N/A | Discretionary |
| May 16, 2024 | DAWN | $43.0K | Sale | 2,675 | $16.08 | Discretionary |
| May 15, 2024 | DAWN | $0 | Option Exercise | 2,250 | $N/A | Discretionary |
| May 15, 2024 | DAWN | $0 | Option Exercise | 6,625 | $N/A | Discretionary |
| May 15, 2024 | DAWN | $0 | Option Exercise | 1,375 | $N/A | Discretionary |
| May 3, 2024 | DAWN | $144.2K | Sale | 8,078 | $17.85 | Planned |
| May 2, 2024 | DAWN | $3.6K | Sale | 200 | $17.90 | Planned |
| May 1, 2024 | DAWN | $933.6K | Sale | 52,183 | $17.89 | Planned |
| Feb 16, 2024 | DAWN | $40.7K | Sale | 2,666 | $15.25 | Discretionary |
| Feb 15, 2024 | DAWN | $0 | Option Exercise | 1,375 | $N/A | Discretionary |
| Feb 15, 2024 | DAWN | $0 | Option Exercise | 2,250 | $N/A | Discretionary |
| Feb 15, 2024 | DAWN | $0 | Option Exercise | 6,625 | $N/A | Discretionary |
| Nov 16, 2023 | DAWN | $11.2K | Sale | 956 | $11.69 | Discretionary |
| Nov 15, 2023 | DAWN | $0 | Option Exercise | 2,250 | $N/A | Discretionary |
| Nov 15, 2023 | DAWN | $0 | Option Exercise | 1,375 | $N/A | Discretionary |
| Aug 17, 2023 | DAWN | $12.8K | Sale | 922 | $13.86 | Discretionary |
| Aug 15, 2023 | DAWN | $0 | Option Exercise | 2,250 | $N/A | Discretionary |